Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lymphoma, T-Cell, Peripheral | 5 | 2023 | 124 | 2.450 |
Why?
|
Lymphoma, T-Cell | 6 | 2024 | 302 | 1.730 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 3 | 2017 | 209 | 1.270 |
Why?
|
Receptors, Immunologic | 2 | 2024 | 1415 | 1.030 |
Why?
|
Mucin-1 | 4 | 2017 | 549 | 0.980 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3529 | 0.960 |
Why?
|
Lymphoma, AIDS-Related | 1 | 2022 | 82 | 0.780 |
Why?
|
Lectins, C-Type | 1 | 2024 | 585 | 0.740 |
Why?
|
Azacitidine | 3 | 2023 | 332 | 0.710 |
Why?
|
Nuclear Physics | 6 | 2014 | 75 | 0.670 |
Why?
|
Depsipeptides | 3 | 2024 | 92 | 0.560 |
Why?
|
Antigens, Differentiation | 1 | 2019 | 846 | 0.560 |
Why?
|
Receptors, IgG | 1 | 2019 | 565 | 0.540 |
Why?
|
Hodgkin Disease | 1 | 2022 | 1378 | 0.460 |
Why?
|
Elementary Particles | 4 | 2014 | 52 | 0.450 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2022 | 2205 | 0.430 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2022 | 1393 | 0.400 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11584 | 0.370 |
Why?
|
Aminopterin | 2 | 2024 | 16 | 0.370 |
Why?
|
Oxidative Stress | 2 | 2017 | 3033 | 0.330 |
Why?
|
Models, Theoretical | 6 | 2014 | 3552 | 0.290 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 16667 | 0.260 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9193 | 0.230 |
Why?
|
Elementary Particle Interactions | 2 | 2013 | 17 | 0.220 |
Why?
|
Peptides | 1 | 2015 | 4321 | 0.220 |
Why?
|
Registries | 1 | 2019 | 8173 | 0.220 |
Why?
|
Cell Proliferation | 2 | 2017 | 10311 | 0.220 |
Why?
|
Apoptosis | 2 | 2017 | 9447 | 0.210 |
Why?
|
Ifosfamide | 1 | 2022 | 231 | 0.200 |
Why?
|
Cancer Vaccines | 3 | 2019 | 1044 | 0.200 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2024 | 235 | 0.190 |
Why?
|
Skin Neoplasms | 2 | 2023 | 5685 | 0.190 |
Why?
|
Ikaros Transcription Factor | 1 | 2022 | 228 | 0.180 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2782 | 0.180 |
Why?
|
Lymphoma, Follicular | 1 | 2024 | 446 | 0.170 |
Why?
|
Exanthema | 1 | 2024 | 500 | 0.170 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2024 | 776 | 0.160 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 2075 | 0.160 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2022 | 682 | 0.160 |
Why?
|
Disease Models, Animal | 3 | 2023 | 17869 | 0.160 |
Why?
|
Oncogenes | 1 | 2023 | 1216 | 0.150 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2019 | 3541 | 0.150 |
Why?
|
Mice | 8 | 2024 | 80251 | 0.140 |
Why?
|
Mesons | 2 | 2014 | 31 | 0.140 |
Why?
|
Multiple Myeloma | 3 | 2022 | 5096 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 925 | 0.140 |
Why?
|
Receptors, Fc | 1 | 2019 | 527 | 0.130 |
Why?
|
Killer Cells, Natural | 1 | 2024 | 2170 | 0.120 |
Why?
|
Cell Nucleus | 1 | 2023 | 2898 | 0.120 |
Why?
|
Flow Cytometry | 2 | 2015 | 5843 | 0.120 |
Why?
|
NADP | 1 | 2015 | 227 | 0.120 |
Why?
|
Neutrons | 1 | 2014 | 77 | 0.120 |
Why?
|
T-Lymphocytes | 3 | 2022 | 10018 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 419 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2015 | 376 | 0.110 |
Why?
|
Animals | 9 | 2024 | 166558 | 0.110 |
Why?
|
Cell Communication | 2 | 2017 | 1625 | 0.110 |
Why?
|
Immunologic Factors | 1 | 2022 | 1567 | 0.110 |
Why?
|
Glutathione | 1 | 2015 | 566 | 0.110 |
Why?
|
Antigens, Neoplasm | 2 | 2017 | 1975 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1854 | 0.100 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1712 | 0.100 |
Why?
|
Oxidation-Reduction | 1 | 2017 | 2187 | 0.100 |
Why?
|
Stromal Cells | 1 | 2017 | 1301 | 0.100 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13586 | 0.100 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2193 | 0.100 |
Why?
|
Humans | 22 | 2024 | 746630 | 0.100 |
Why?
|
Remission Induction | 1 | 2016 | 2369 | 0.090 |
Why?
|
Necrosis | 1 | 2015 | 1596 | 0.090 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1809 | 0.090 |
Why?
|
Drug Synergism | 1 | 2015 | 1734 | 0.090 |
Why?
|
Skin | 1 | 2024 | 4389 | 0.090 |
Why?
|
Mice, SCID | 1 | 2015 | 2621 | 0.090 |
Why?
|
Dendritic Cells | 2 | 2019 | 2713 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2015 | 1137 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2022 | 5166 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2019 | 3695 | 0.080 |
Why?
|
Coculture Techniques | 3 | 2017 | 1328 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6789 | 0.080 |
Why?
|
Immunotherapy, Adoptive | 1 | 2017 | 1393 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4586 | 0.080 |
Why?
|
Blotting, Western | 1 | 2015 | 5052 | 0.070 |
Why?
|
Protons | 1 | 2013 | 1116 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4516 | 0.070 |
Why?
|
Tumor Cells, Cultured | 1 | 2015 | 6142 | 0.070 |
Why?
|
Antibodies, Monoclonal | 1 | 2024 | 9107 | 0.070 |
Why?
|
Transfection | 1 | 2015 | 5789 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2902 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7229 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 2931 | 0.060 |
Why?
|
Immunosuppressive Agents | 1 | 2018 | 4057 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2856 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12645 | 0.060 |
Why?
|
Vaccination | 1 | 2016 | 3283 | 0.060 |
Why?
|
Immunoblastic Lymphadenopathy | 1 | 2024 | 40 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2024 | 34 | 0.060 |
Why?
|
Folic Acid Antagonists | 1 | 2024 | 76 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2024 | 173 | 0.060 |
Why?
|
Acetyl Coenzyme A | 1 | 2023 | 74 | 0.060 |
Why?
|
Co-Repressor Proteins | 1 | 2023 | 191 | 0.050 |
Why?
|
Perineum | 1 | 2024 | 208 | 0.050 |
Why?
|
Doxycycline | 1 | 2024 | 334 | 0.050 |
Why?
|
Transcription Factor AP-1 | 1 | 2023 | 318 | 0.050 |
Why?
|
Anal Canal | 1 | 2024 | 373 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2017 | 8356 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2015 | 12767 | 0.040 |
Why?
|
Glycolysis | 1 | 2023 | 814 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2023 | 1059 | 0.040 |
Why?
|
Abdomen | 1 | 2024 | 1104 | 0.040 |
Why?
|
Aged | 5 | 2024 | 164383 | 0.040 |
Why?
|
Cross-Priming | 1 | 2017 | 76 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2019 | 38771 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2015 | 21693 | 0.040 |
Why?
|
Perforin | 1 | 2017 | 169 | 0.040 |
Why?
|
Ubiquitination | 1 | 2022 | 994 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2023 | 1753 | 0.040 |
Why?
|
Virus Activation | 1 | 2019 | 316 | 0.040 |
Why?
|
Thalidomide | 1 | 2022 | 882 | 0.030 |
Why?
|
Retroviridae | 1 | 2019 | 849 | 0.030 |
Why?
|
Female | 6 | 2024 | 382450 | 0.030 |
Why?
|
Signal Transduction | 2 | 2017 | 23154 | 0.030 |
Why?
|
Isoantigens | 1 | 2017 | 496 | 0.030 |
Why?
|
Neoplasm Transplantation | 1 | 2019 | 2013 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1341 | 0.030 |
Why?
|
Janus Kinase 2 | 1 | 2017 | 534 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 214618 | 0.030 |
Why?
|
Tumor Suppressor Proteins | 1 | 2023 | 2793 | 0.030 |
Why?
|
Prednisone | 1 | 2018 | 1559 | 0.030 |
Why?
|
Adult | 4 | 2024 | 215192 | 0.030 |
Why?
|
Electrons | 1 | 2014 | 261 | 0.030 |
Why?
|
Immunity, Cellular | 1 | 2019 | 1550 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 870 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 593 | 0.030 |
Why?
|
Biopsy | 1 | 2024 | 6734 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 983 | 0.020 |
Why?
|
Down-Regulation | 1 | 2019 | 2908 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2017 | 982 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 801 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 63732 | 0.020 |
Why?
|
Gene Silencing | 1 | 2017 | 1513 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 2017 | 1824 | 0.020 |
Why?
|
Transplantation, Homologous | 1 | 2018 | 4622 | 0.020 |
Why?
|
Male | 4 | 2024 | 351420 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2017 | 3143 | 0.020 |
Why?
|
Pain | 1 | 2024 | 4982 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12840 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2119 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2017 | 5416 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15312 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4259 | 0.020 |
Why?
|
Gene Expression | 1 | 2017 | 7590 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12044 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3012 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9124 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 25184 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7236 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2024 | 20143 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2019 | 21600 | 0.010 |
Why?
|
MicroRNAs | 1 | 2017 | 3748 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2017 | 11384 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2018 | 5458 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2024 | 57586 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 40534 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 78313 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 57163 | 0.010 |
Why?
|
Concepts
(165)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_